Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...

Under the terms of the partnership, Yorktown FC will: select and recommend young, qualified Ghanaian players for training at ...

Artiva Biotherapeutics, Inc. (ARTV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

With Alabama's dominant 42-13 win, LSU’s playoff hopes officially slipped away. The Tigers came into the game hoping to keep ...

Q3 2024 Earnings Call Transcript November 8, 2024 Y-mAbs Therapeutics, Inc. reports earnings inline with expectations.

Nkarta’s course toward lupus was set last year and then reaffirmed in March when the company deprioritized a CAR NK candidate after data from 14 patients with acute myeloid leukemia failed to live up ...

Initial trials using CAR T cells in patients with autoimmune ... including CD4/CD8 T cells, regulatory T cells, NK cells, and innate immune cells - Applications to a growing list of autoimmune ...

Satellite imagery show progress in the construction of two major hospitals under construction in Pyongyang's Taedong River ...

Nithin and Nikhil Kamath broke barriers to build Zerodha at a blistering pace amid India's rising stock markets. New rules to ...